Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
In the current era of treat-to-target strategies, therapeutic drug monitoring (TDM) has emerged as a potential tool in optimizing the efficacy of biologics for children diagnosed with inflammatory bowel disease (IBD). The incorporation of TDM into treatment algorithms, however, has proven to be comp...
Saved in:
Main Authors: | Akshay Kapoor (Author), Eileen Crowley (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
by: Kaija-Leena Kolho, et al.
Published: (2021) -
New Frontiers in Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
Published: (2023) -
Potential Role of Methotrexate Polyglutamates in Therapeutic Drug Monitoring for Pediatric Inflammatory Bowel Disease
by: Ryan Morrow, et al.
Published: (2021) -
Biological Therapy for Inflammatory Bowel Disease
Published: (2020) -
Dual biological therapy and small molecules in pediatric inflammatory bowel disease
by: Francesca Penagini, et al.
Published: (2023)